https://www.selleckchem.com/pr....oducts/tuvusertib.ht
96; SD = 4.32; 0.01; ES = 0.68) and from pre-treatment to six weeks following the end of treatment ( = 4.53; SD = 3.16; 0.001; ES = 1.43). There was no significant difference in the gain from pre-treatment to post-treatment for the Web ORLA versus Control groups. However, the Web ORLA group showed significantly greater gains at the six-week follow-up than the control group ( = 2.70; SD = 1.01; = 0.013; ES = 1.92). Results provide evidence for improved language outcomes following intensive, web-based delivery of ORLA to
Beğen
Yorum Yap
Paylaş
